To elucidate the role of EpCAM in breast cancer progression, an EpCAM overexpression plasmid and small interfering RNA-mediated silencing of EpCAM (si-EpCAM) were used to increase and reduce EpCAM expression in MCF-7 and MDA-MB-231 breast cancer cell lines, respectively. Here, EPCAM is linked to breast cancer.